david subject medical news part 14 cut volume 6 number 11 april 25 1993 health network medical newsletter editor david north street suite 210 arizona usa telephone 1 602 fax 1 602 compilation copyright 1993 david right reserved license hereby granted electronic medium fee charged long text thi copyright notice license attached intact portion portion health network newsletter distributed article medical nature welcomed article please contact editor information submit interested joining automated distribution system please contact editor email addres editor internet fidonet bitnet listserv internet anonymou ftp list fax delivery contact editor information b l e f c n e n 1 center disease control prevention 23 april 1993 rate cesarean delivery 1 malarium among u embassy personnel 5 fda approval vaccine 8 2 news workshop explore oral manifestation hiv infection 11 3 food drug administration news fda approve 14 new rule speed approval drug illness 16 4 article research promise disease 18 diet increase risk heart disease 20 5 general publication health professional national cancer institute 23 publication patient available national cancer institute 30 6 aid news summary aid daily summary april 19 april 23 1993 38 7 aid statistic worldwide aid statistic 48 hicnet medical newsletter page volume 6 number 11 april 25 1993 center disease control prevention rate cesarean delivery united state 1991 source date apr 23 1993 cesarean delivery nearly 1 million approximately 4 million annual delivery united state since 1986 table 1 cesarean rate united state third highest among 21 reporting country 1 thi report present datum cesarean delivery cdc national hospital discharge survey 1991 compare datum previou year datum discharge hospital collected since 1965 conducted cdc national center health statistic 1991 medical information sample participating hospital 1991 cesarean vaginal birth prior cesarean presented thi report based national estimate sample approximately 11 woman delivery estimated number live birth type delivery calculated applying cesarean rate live birth national vital registration datum therefore estimate number cesarean thi report agree previously published datum based solely 2 stated difference thi analysi significant 95 confidence level based critical value 196 1991 235 cesarean per 100 delivery rate 1990 similar rate table 1 primary cesarean rate ie number first cesarean per 100 delivery woman previou cesarean also wa stable ranging 168 175 1991 cesarean rate south wa significantly higher rate west midwest 226 rate higher mother aged greater equal 30 year younger woman proprietary hospital nonprofit government hospital hospital fewer 300 bed larger hospital delivery blue shield private insurance expected source payment source payment table 2 pattern characterized primary cesarean delivery since early 1970 number percentage birth older woman increased however age distribution mother 1991 remained 1986 overall cesarean rate 1991 would 233 essentially 235 observed based approximately live birth 1991 hicnet medical newsletter page 1 volume 6 number 11 april 25 1993 estimated 235 cesarean delivery estimated 350 birth repeat cesarean 650 primary cesarean since 1986 approximately primary cesarean performed 1986 85 woman previou cesarean delivered compared 1991 cesarean 1991 350 associated previou cesarean ie failure labor progress 117 presentation 92 distres specified average hospital stay delivery 1991 wa 28 day comparison hospital stay primary cesarean delivery wa 45 day repeat cesarean 42 day nearly twice duration delivery 22 day vaginal delivery 23 day 1986 average hospital stay delivery wa 32 day primary cesarean 52 day repeat cesarean 47 day vaginal delivery 27 26 day respectively reported office vital health statistic system national center health statistic cdc editorial note cesarean rate united state increased 1965 1986 however finding thi report indicate rate stable since 1986 3 little evidence child health statu ha improved thi time cesarean associated increased risk national health objective year 2000 4 reduce overall cesarean rate 15 fewer per 100 delivery primary cesarean rate 12 fewer per 100 delivery objective 148 including tract wound infection may account part longer hospital stay cesarean delivery vaginal birth 5 moreover hospital stay cesarean delivery substantially increase cost example 1991 average cost cesarean vaginal delivery respectively additional cost cesarean delivery include physician fee hospital charge 6 cesarean rate 1991 15 year 2000 objective instead 235 number cesarean birth would decreased versu resulting saving 1 billion physician fee hospital charge despite steady increase rate since 1986 several factor may progress toward year 2000 national health objective cesarean delivery example rate substantially reflect number woman offered trial labor ha increasingly encouraged since 1982 7 woman offered trial labor could deliver 7 level already achieved many hospital 8 trial labor wa routinely offered 46 hospital 1984 recent year hicnet medical newsletter page 2 volume 6 number 11 april 25 1993 national datum available 9 rate according datum wa 57 year 2000 objective specify rate 35 based woman prior cesarean regardles whether trial labor wa attempted reach overall cesarean rate goal however increase rate need combined substantial reduction primary rate one hospital succeeded reducing rate cesarean delivery applying objective criterium fmy common indication cesarean delivery requiring second opinion proces 10 recommendation cesarean delivery rate include eliminating incentive physician hospital vaginal cesarean delivery public physician cesarean delivery rate increase public awarenes difference practice addressing concern may important factor maintaining high rate cesarean delivery 4 reference 1 fc international difference use intervention 1990 2 grave 1991 summary national hospital discharge survey maryland u department health human service public health service cdc 1993 advance datum 3 sm u cesarean section rate 1990 update birth 4 public health service healthy person 2000 national health promotion disease prevention objective full report commentary washington dc u department health human service public health service 1991 publication 5 dn cesarean section 6 hospital insurance association america table 415 cost care physician fee hospital charge region based consumer price index 1991 1992 source book health insurance datum washington dc hospital insurance association america 1992 7 committee committee opinion 64 guideline vaginal delivery previou cesarean birth washington dc american college 1988 hicnet medical newsletter page 3 volume 6 number 11 april 25 1993 8 mg jc vaginal birth cesarean indicator succes 9 ph recent trend cesarean birth trial labor rate united state 10 myer sa n successful program lower rate n j med use trade name commercial source identification imply public health service u department health human service hicnet medical newsletter page 4 volume 6 number 11 april 25 1993 malarium among u embassy personnel 1992 source date apr 23 1993 treatment prevention malarium africa ha become complex problem increasing drug resistance although risk malarium u citizen dependent oversea generally ha low thi risk vary substantially may 1992 office medical service department state cdc increased number malarium case among official u personnel review health record embassy health unit indicated 27 case malarium diagnosed official personnel march june 1992 compared two case period 1991 cdc conducted investigation confirm reported malarium case identify potential risk factor malarium among u embassy personnel thi report summarize result investigation malarium blood 25 27 reported available review cdc case malarium wa confirmed slide wa positive sp 25 person 17 slide confirmed malarium wa distributed person served obtain information residence activity use malarium use personal protection measure ie using insect window door screen wearing long sleeve pant evening 157 person survey 128 82 responded risk malarium wa associated sex location residence although risk malarium wa higher among child aged le equal 15 year 19 among person greater 15 year 12 thi difference wa significant relative risk 95 confidence interval percent case occurred among person living 15 year compared living le 1 year travel outside area setting wa associated increased risk malarium fmy malarium used person participated survey alone alone addition 23 18 person responded using malarium risk malarium wa significantly lower among person using either 9 among person using 24 95 twelve person using reported side effect fear possible side effect reason risk malarium wa lower among person reported using hicnet medical newsletter page 5 volume 6 number 11 april 25 1993 time 7 among person sometime rarely used 15 95 risk malarium wa also lower among person consistently used insect evening compared rarely used 15 upper 95 confidence risk malarium wa associated failure window door screen wear long sleeve pant evening result thi investigation staff reviewed personnel need use comply recommended malarium staff also need use personal protection measure made plan obtain provide window door screen personnel reported u embassy health unit office medical dept state washington dc malarium br div disease national center infectiou disease cdc editorial note increase malarium among u personnel wa attributed poor recommended malarium use personal protection measure period increased malarium transmission resistance africa finding thi report need provide initial continued regarding malarium prevention person living abroad area measure also important area effective africa area p however area eg resistance may limit effectivenes africa compared alone preventing infection p 92 1 safe well given 250 mg per week period risk seriou reaction possibly associated eg low ie episode per 100000 user 2 risk le severe reaction eg complaint sleep similar 1 ha similar need daily may reduce compliance effectivenes thi 34 alone effective area intense resistance eg asium africa africa person take alternative although le effective used malarium prevention area p ha reported recommendation preventing malarium information hicnet medical newsletter page 6 volume 6 number 11 april 25 1993 precaution malarium available health information international travel 1992 ie yellow book 5 24 hour day telephone fax reference 1 ho eng et al longterm malarium weekly peace corp volunteer effective well 2 world health organization review central nervou system event related drug world health organization 1991 publication 3 l n p treatment malarium j di 4 l n p malarium 5 cdc health information international travel 1992 atlantum u department health human service public health service publication hicnet medical newsletter page 7 volume 6 number 11 april 25 1993 fda approval use new b vaccine combined b vaccine infant child source date apr 23 1993 type b vaccine recommended use infant since 1990 routine use infant ha contributed substantial decline incidence disease united state 13 vaccine childhood routinely united state since late 1940 ha associated greater 90 reduction associated infection organism increasing number vaccine routinely recommended infant high priority development combined vaccine allow administration fewer separate injection food drug administration fda recently licensed two new product child disease 1 b vaccine trademark disease 2 combined vaccine vaccine trademark combination vaccine use child disease trademark march 30 1993 fda approved new b vaccine manufactured serum et distributed trademark laboratory inc pennsylvanium thi vaccine ha licensed use infant primary series age 2 4 6 month previously infant month age receive two dose 2 month apart previously child month age receive one dose booster dose 15 month age recommended child previously child month age receive single dose require booster 90 infant receiving primary series trademark consecutive dose 2 4 6 month age develop geometric mean b antibody greater 1 4 thi response similar infant receive recommended series previously licensed b vaccine ha demonstrated trial two u trial terminated early b vaccine hicnet medical newsletter page 8 volume 6 number 11 april 25 1993 use infant 4 study case disease detected approximately 6000 infant study suggest vaccine similar licensed vaccine trademark march 30 1993 fda approved combined vaccine b vaccine trademark available biological river new york combine two previously licensed product registered manufactured laboratory river new york b vaccine registered manufactured inc rochester new york thi vaccine ha licensed use child aged 2 year protection disease indication vaccine b vaccine based demonstration co higher antibody response component two vaccine trademark expected provide protection well equivalent already licensed b vaccine advisory committee immunization practice recommend infant receive primary series one licensed b vaccine beginning 2 month age booster dose age 12 15 month 5 also recommend infant receive primary series vaccine 2 4 6 month age booster dose 46 year 68 complete statement regarding recommendation use trademark trademark developed reported office vaccine research review center evaluation research food drug administration div immunization national center prevention special br div disease national center infectiou disease cdc reference 1 adam ka sl et al decline childhood type b disease vaccine era 2 le erickson kelley decrease disease u army child 1984 1991 3 murphy tv white pastor p et al incidence type b disease since introduction hicnet medical newsletter page 9 volume 6 number 11 april 25 1993 4 b safety type b protein vaccine j 5 b vaccine prevention type b disease among infant child two month age older recommendation immunization practice advisory committee 6 recommendation vaccine use measure recommendation immunization practice advisory committee 7 vaccine booster use statement recommendation immunization practice advisory committee 8 vaccine fourth fifth dose series update statement recommendation immunization practice advisory committee use trade name commercial source identification imply public health service u department health human service hicnet medical newsletter page 10 volume 6 number 11 april 25 1993 news international workshop explore oral manifestation hiv infection research digest written jody march 1993 national institute research second international workshop oral manifestation hiv infection held january 3 san francisco participant issue related basic molecular oral clinical presentation hiv infection workshop wa organized dr john dr department school university californium san francisco international steering committee scientific program committee provided guidance conference drew scientist 39 country including asium africa europe central america south america well united state canada support tor workshop wa provided national institute research national cancer institute national institute allergy infectiou disease nih office aid research company among topic discussed hiv ethic professional responsibility public policy issue provision oral care population hiv transmission infection hiv infection woman issue recommendation recommendation workshop define association appearance oral rate progression hiv establish universal terminology oral look effective treatment oral manifestation expand molecular biology study understand relationship hiv infection common oral study effect hiv therapy oral since first international workshop oral manifestation hiv infection wa five year ago hiv infection ha hicnet medical newsletter page 11 volume 6 number 11 april 25 1993 changed 1988 hiv infection wa detected reported largely homosexual male drug user today hiv infection seen heterosexual male female child impact hiv infection ha felt africa major increase infection rate seen asium well five hundred thousand case reported date thi region appearing time researcher continuing document oral also beginning explore relationship specific oral hiv disease progression issue discussion social political implication hiv infection changing public attitude aid sexual behavior drug use speaker also addressed health care delivery patient need educate public aid acquired conference speaker described transmission issue activity strength vary among different whole ha greater effect turn greater effect research ha shown least two mechanism responsible activity attributed effect 1 hiv may promote clearance viru prevent reaching target cell 2 direct effect viru target cell topic discussed manifestation disease person current research oral issue aid recently ha area intense interest early accurate diagnosi proper treatment life hiv infected child ha prevention transmission hiv mother child may possible many case particularly mother known prior giving birth tissue disease hicnet medical newsletter page 12 volume 6 number 11 april 25 1993 oral health researcher continue explore disease found individual hiv infection recommendation made workshop include terminology diagnostic study design proper consideration variable resulting therapy treatment issue issue surrounding treatment individual treatment rendered health care professional still command considerable attention factor consideration include hiv testing care provider transmission hiv infection reverse use mainstream versu dedicated facility treatment patient conference participant third international workshop oral manifestation hiv infection held five year le proceeding second workshop published company late 1993 end part 1 internet fax 1 602 bitnet fidonet amateur packet
